Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes.
Sarak B, Verma S, David Mazer C, Teoh H, Quan A, Gilbert RE, Goodman SG, Bami K, Coelho-Filho OR, Ahooja V, Deva DP, Garg V, Gandhi S, Connelly KA, Yan AT.
Sarak B, et al. Among authors: deva dp.
Cardiovasc Diabetol. 2021 Oct 4;20(1):200. doi: 10.1186/s12933-021-01390-8.
Cardiovasc Diabetol. 2021.
PMID: 34607574
Free PMC article.
Clinical Trial.